跳至主要内容
临床试验/NCT02904785
NCT02904785Unknown2 期

The Efficacy of Extracorporeal Focused Shock Wave Therapy for Patients With Primary Knee Osteoarthritis

University of Sao Paulo General Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2016年5月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
入组人数
30
试验地点
1
主要终点
Knee Pain after one month

研究概览

简要总结

The purpose of this study is to determine whether Extracorporeal Focused Shock Wave Therapy reduces knee pain and enhance function in patients with primary knee osteoarthritis.

详细描述

This study is a placebo controlled Randomized Clinical Trial (RCT) in which the primary outcome is to determine whether Extracorporeal Focused Shock Wave Therapy (ESWT) reduces knee pain comparing the VAS at baseline and one month after the end of the treatment. Function assessment and progression of pain along the treatment are the secondary outcomes. Function will be assessed with the Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC), the Lequesne's Algofunctional Questionnaire for Osteoarthritis of Knee (Lequesne) and the Timed up and Go (TUG).

The ESWT applications will be performed once a week for four consecutive weeks, the patients will be assessed for pain and function before the beginning of the treatment and one week after every application of the ESWT.

The treatment groups will be randomized. The allocation of the patients is sealed and will not be disclosed to the patients nor to the evaluators.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical and radiologic diagnosis of primary knee osteoarthritis (Kellgren & Lawrence I, II or III);
  • Capability to understand the Informed Consent Form;
  • Chronic pain for at least 3 months prior to inclusion, measured by VAS. (VAS 4 or above);
  • Absence of skin injures, infections or tumor in the target knee;
  • Availability to comply with the visits.

排除标准

  • History of spinal cord stenosis or clinical symptoms of lumbar radiculopathy;
  • History or onset neurological diseases;
  • Generalized pain or fibromyalgia;
  • Inability to walk;
  • History of knee surgery in the target knee;
  • Secondary causes of osteoarthritis;
  • Use of statins and quinolones in the previous year;
  • Uncontrolled and ongoing psychiatric diseases;
  • Invasive knee treatments with hyaluronic acid infusion, corticosteroids and anaesthetics, in the target knee, up to 6 months previous to study inclusion.

研究组 & 干预措施

Extracorporeal Shock Waves

Experimental

Focused shock waves delivered by an electromagnetic generator with a focus of 5.0cm deep on the affected knee in three different positions. A total of 7000 pulses will be delivered on a weekly session for four weeks.

干预措施: Extracorporeal Shock Waves (Device)

Extracorporeal Shock Waves

Experimental

Focused shock waves delivered by an electromagnetic generator with a focus of 5.0cm deep on the affected knee in three different positions. A total of 7000 pulses will be delivered on a weekly session for four weeks.

干预措施: Physical activities (Other)

Sham Extracorporeal Shock Waves

Sham Comparator

Sham focused shock waves delivered by an electromagnetic generator on the affected knee in three different positions. A total of 7000 pulses will be delivered on a weekly session for four weeks. A foam will be placed in the probe as to stop the energy to be transmitted to the patient's knee, so no focused shockwaves will be delivered.

干预措施: Sham Extracorporeal Shock Waves (Device)

Sham Extracorporeal Shock Waves

Sham Comparator

Sham focused shock waves delivered by an electromagnetic generator on the affected knee in three different positions. A total of 7000 pulses will be delivered on a weekly session for four weeks. A foam will be placed in the probe as to stop the energy to be transmitted to the patient's knee, so no focused shockwaves will be delivered.

干预措施: Physical activities (Other)

结局指标

主要结局

Knee Pain after one month

时间窗: One month

Mean change in Visual Analogue Scale (VAS) score one month after the end of the treatment compared to baseline.

次要结局

  • WOMAC Knee Function after three months(Three months)
  • WOMAC Knee Function progression(One week after each of four weekly ESWT applications)
  • TUG Knee Function progression(One week after each of four weekly ESWT applications)
  • Lequesne Knee Function after three months(Three months)
  • Knee pain progression(One week after each of four weekly ESWT applications)
  • Knee Pain after three months(Three months)
  • Lequesne Knee Function progression(One week after each of four weekly ESWT applications)
  • TUG Knee Function after three months(Three months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Linamara Rizzo Battistella, MD PhD

PhD

University of Sao Paulo General Hospital

研究点 (1)

Loading locations...

相似试验